Guggenheim Capital’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-11,790
| Closed | -$65K | – | 2641 |
|
|
2018
Q1 | $65K | Buy |
11,790
+269
| +2% | +$1.48K | ﹤0.01% | 2689 |
|
|
2017
Q4 | $93K | Sell |
11,521
-1,810
| -14% | -$14.6K | ﹤0.01% | 2607 |
|
|
2017
Q3 | $139K | Buy |
13,331
+52
| +0.4% | +$542 | ﹤0.01% | 2638 |
|
|
2017
Q2 | $145K | Sell |
13,279
-32
| -0.2% | -$349 | ﹤0.01% | 2671 |
|
|
2017
Q1 | $110K | Buy |
13,311
+8
| +0.1% | +$66 | ﹤0.01% | 2684 |
|
|
2016
Q4 | $93K | Buy |
13,303
+38
| +0.3% | +$266 | ﹤0.01% | 2771 |
|
|
2016
Q3 | $68K | Buy |
13,265
+8
| +0.1% | +$41 | ﹤0.01% | 2753 |
|
|
2016
Q2 | $79K | Buy |
13,257
+1,250
| +10% | +$7.45K | ﹤0.01% | 2748 |
|
|
2016
Q1 | $55K | Buy |
12,007
+1,333
| +12% | +$6.11K | ﹤0.01% | 2796 |
|
|
2015
Q4 | $48K | Buy |
+10,674
| New | +$48K | ﹤0.01% | 2895 |
|
|
2015
Q2 | – | Sell |
-13,128
| Closed | -$38K | – | 3103 |
|
|
2015
Q1 | $38K | Buy |
13,128
+1,810
| +16% | +$5.24K | ﹤0.01% | 2949 |
|
|
2014
Q4 | $50K | Buy |
+11,318
| New | +$50K | ﹤0.01% | 2907 |
|
|
2014
Q3 | – | Sell |
-22,259
| Closed | -$117K | – | 3072 |
|
|
2014
Q2 | $117K | Buy |
22,259
+2,719
| +14% | +$14.3K | ﹤0.01% | 2940 |
|
|
2014
Q1 | $81K | Buy |
19,540
+4,441
| +29% | +$18.4K | ﹤0.01% | 3002 |
|
|
2013
Q4 | $44K | Buy |
15,099
+896
| +6% | +$2.61K | ﹤0.01% | 3006 |
|
|
2013
Q3 | $36K | Buy |
14,203
+2,027
| +17% | +$5.14K | ﹤0.01% | 2912 |
|
|
2013
Q2 | $25K | Buy |
+12,176
| New | +$25K | ﹤0.01% | 2888 |
|